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Background
Immunologically self carbohydrates protect the human
immunodeficiency virus type -1 (HIV-1) surface glycopro-
tein, gp120 from antibody recognition. However, one
broadly neutralising antibody, 2G12, can protect against
primary viral challenge by direct recognition of these
"self" glycans on gp120. Immunogens capable of eliciting
antibodies of similar specificity are candidates for HIV/
AIDS vaccine design. The polysaccharides of common
yeasts exhibit significant structural and antigenic mimicry
with the immunologically "self" glycans of gp120; 2G12
also recognises yeast mannans.
Methods
Wild-type and genetically modified Saccharomyces cerevi-
siae was used to intravenously inoculate rabbits. Sera from
these animals was subjected to gp120-binding ELISAs,
carbohydrate microarray analysis, and ex vivo neutralisa-
tion assay.
Results
Here we report that manipulation of yeast mannan bio-
synthesis controls the molecular specificity of cross-reac-
tive antibodies to gp120. Carbohydrate microarray
analysis of gp120-reactive sera produced following immu-
nization by Saccharomyces cerevisiae (SCWT) revealed
serum with high reactivity to "self" Man8GlcNAc2 gly-
cans. In contrast, immunisation with S. cerevisiae deficient
for the Mnn1 a1,3 mannosyl transferase gene (SCMnn1),
elicited gp120-reactive antibodies directed to
Man9GlcNAc2 glycans. Terminal Mana1-3 linkages that
cap the common repeating (Mana1-2Man) core motif are
absent in the SCMnn1 strain.
Conclusion
These data reveal that anti-carbohydrate antibodies that
bind gp120 can be reliably elicited by microbial mimicry.
The specificities of these antibodies can be controlled by
genetic manipulation of mannan biosynthesis, suggesting
a route towards HIV vaccine design.
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